Zeskind Benjamin J.'s Form 4 filing
Immuneering Corp (IMRX) · filed Aug 4, 2021
- Accession no.
- 0001104659-21-099741
- Filed
- Aug 4, 2021
- Trade date
- Aug 3, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $31.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zeskind Benjamin J.CIK 0001870062 | Director, Officer (President and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Class A Common Stock | CConversionAcquired | +49,099 | – | – | 2,598,171 | Direct | |
| Aug 3, 2021 | Class A Common Stock | PPurchaseAcquired | +2,098 | $15.00 | +$31,470 | 2,600,269 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Class A Common Stock | CConversionDisposed | −40,928 | – | – | 0 | Direct | |
| Aug 3, 2021 | Class A Common Stock | CConversionDisposed | −8,171 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.